Keyphrases
Prostate Cancer
82%
Prostate Cancer Risk
51%
Statins
24%
Radical Prostatectomy
21%
Androgen Deprivation Therapy
21%
Statin Use
19%
Finland
18%
Prostate Cancer Screening
14%
Antidiabetic Drugs
13%
Drug Use
12%
Three-dimensional (3D)
12%
Prostatectomy
11%
Atorvastatin
11%
Functional Outcome
11%
Metastatic Hormone-sensitive Prostate Cancer (mHSPC)
10%
Prostate-specific Antigen
10%
Cancer Mortality
10%
Non-steroidal Anti-inflammatory Drugs (NSAIDs)
10%
National Cohort Study
10%
High-grade Prostate Cancer
9%
Hazard Ratio
9%
Prostate Cancer Survival
9%
Population-based Cohort Study
9%
Laparoscopic Prostatectomy
9%
Confidence Interval
9%
Prostate Radiotherapy
8%
Prostate
8%
Prostate Cancer Prognosis
8%
Population-based Cohort
7%
Expanded Prostate Cancer Index Composite
7%
Screening Trials
7%
Castration-resistant Prostate Cancer
7%
Overall Survival
7%
Randomized Clinical Trial
7%
Metformin
7%
Prostate Cancer Patients
7%
Prostate Cancer Progression
7%
Breast Cancer
6%
Antihypertensive Drugs
6%
Randomized Controlled Trial
6%
Cholesterol Levels
6%
EPIC-26
6%
Laparoscopic Radical Prostatectomy
6%
Polygenic Risk Score
6%
Visual Analog Scale
6%
Renal Cancer
6%
Antiepileptic Drugs
6%
Population-based Case-control Study
6%
Finnish Population
6%
Inguinal Hernia Repair
6%
Pharmacology, Toxicology and Pharmaceutical Science
Prostate Cancer
100%
Statin (Protein)
25%
Cancer Mortality
19%
Cohort Study
18%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
15%
Androgen
14%
Prostate Specific Antigen
14%
Malignant Neoplasm
14%
Non-Steroidal Anti-Inflammatory Drug
13%
Cancer Survival
11%
Cancer Prognosis
10%
Castration Resistant Prostate Cancer
10%
Atorvastatin
8%
Antidiabetic Agent
8%
Cancer Incidence
7%
Neoplasm
7%
Antihypertensive Agent
6%
Anticonvulsive Agent
6%
Breast Cancer
6%
Case-Control Study
6%
Acetylsalicylic Acid
6%
Comorbidity
5%
Androgen Receptor
5%
Biological Marker
5%
Diseases
5%
Metastasis
5%
Simvastatin
5%
Medicine and Dentistry
Prostate Cancer
72%
Prostatectomy
33%
Cancer Mortality
12%
Prostate Specific Antigen
11%
Neoplasm
10%
Cohort Analysis
10%
Antidiabetic Agent
9%
Cancer Growth
7%
Urinary System
7%
Cancer Cell
7%
Androgen Deprivation Therapy
7%
Randomized Controlled Trial
6%
Visual Analog Scale
6%
Hernioplasty
6%
Inguinal Hernia
6%
Personalized Medicine
6%
Malignant Neoplasm
5%
Continence
5%
Statin
5%
Incontinence
5%
Urine Incontinence
5%
Enuresis
5%